Resultsbee.com

Results For: "Chemotherapy And Radiation"
Sponsored Links
  • 01

    News Delivered to your Browserstar-rating

    newsprompt.co | Breaking News - Across all newspapers. No signup required.
    See It
  • 02

    Fact-based blogs every daystar-rating

    blogbliss.net | Stay Informed: Daily Fact-Based Blogs to Enlighten Your Mind
    See It

Interested in "Chemotherapy And Radiation"?

Lymphoma is a form of cancer that affects the lymphatic system, the body's disease-fighting network consisting of multiple lymph nodes and vessels that move lymph fluid across the body. Lymph fluid contains infection-fighting white blood cells called lymphocytes, which can become infected and turn cancerous instead of protecting the body from infec

Read More

Refine by

Reset All
Brands
  • 2001 Santa Monica Boulevard, #1190w,Santa Monica,CA

    The Hyperthermia Cancer Institute (HCI) is the only ultrasound-based hyperthermia center in Santa Monica, CA, and one of only a few in the United States. We serve the greater Los Angeles area and have many patients who travel to us from outside California. HCI is led by Dr. Joseph J. Pinzone and providers who are passionate about helping patients with cancer. We partner with you and your doctor to enhance your cancer care and improve your health and the outcome of your treatments. Using this non-invasive, FDA-approved therapy, we can substantially increase the effectiveness of radiation therapy and chemotherapy in many tumor types, and improve treatment outcomes.

    (188) 858 - 0590

    7 MI
  • 2121 Santa Monica Blvd Garden Level,Santa Monica,CA

    Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

    (131) 058 - 2710

    8 MI
  • 7188 W Sunset Blvd Ste 207,Los Angeles,CA

    Non Emergency Medical Transportation . We service all medical appointments, Hospital discharges, chemotherapy, radiation, dialysis.Private transportation.

    (132) 387 - 4002

    15 MI
  • 1245 Wilshire Blvd Suite 303,Los Angeles,CA

    Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

    (180) 020 - 3551

    16 MI
  • 181 S Buena Vista St Disney Family Cancer Center, 2nd Floor,Burbank,CA

    When paired with traditional methods, complementary therapies have proven to be effective in supporting cancer patients. Providence provides acupuncture, massage, herbal medicine and nutritional counseling, yoga, guided imagery, meditation, Tai Chi, therapeutic touch and Qi Gong - all used in addition to conventional cancer treatments such as surgery, radiation therapy and chemotherapy. These therapies help patients through conventional treatments, which can often be emotionally and physically draining. By giving patients access to a broad range of proven therapies, we ultimately give them more control over their cancer treatment.

    (181) 874 - 8470

    19 MI
  • 240 South Jackson Street Suite 109,Glendale,CA

    Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

    (180) 020 - 3551

    20 MI

Most Popular Questions